Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Amgen Inc.   (ticker: AMGN)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for AMGN
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :          Hold          (Click Here For Details)
INSIDERS' Score: 40
0 100 40
Latest 1 month: 0 2,425
Latest 6 Months: 0 26,276
52 Weeks: 0 56,053
Gurus' Indicator :          Hold          (Click Here For Details)
GURUS' Score: 50
0 100 50
Current Holdings: 7,421,467
Previous Holdings: 6,827,687
Change: 8.70%
Institutions' Indicator :          Hold          (Click Here For Details)
0 100 50
Current Holdings: 414,762,449
Previous Holdings: 398,269,112
Change: 4.14%
News And Links For The Group (Contribute a link)
[AMGN]   4 RNA Therapy Stocks For A Biotech Portfolio  (Seeking Alpha)   7-Nov-19 14:20
[AMGN]   Amgen Pops $2.7 Bln Dose Of Risky Chinese Medicine  (Seeking Alpha)   6-Nov-19 03:24
[AMGN]   Galera Therapeutics And Amgen In Severe Oral Mucositis  (Seeking Alpha)   4-Nov-19 16:23
[AMGN]   Week In Review: BeiGene Forms Blockbuster $2.7 Billion Collaboration With Amgen  (Seeking Alpha)   3-Nov-19 13:38
[AMGN]   IPO Update: Centogene Proposes U.S. IPO Terms  (Seeking Alpha)   31-Oct-19 08:44
[AMGN]   Biogen Aducanumab Reversal Is Stunning, But Don't Expect A Repeat For Other Alzheimer's Drugs  (Seeking Alpha)   24-Oct-19 15:20
[AMGN]   Centogene Files Initial Registration Statement For U.S. IPO  (Seeking Alpha)   16-Oct-19 14:16
[AMGN]   Financial Independence Portfolio - September 2019 Update  (Seeking Alpha)   16-Oct-19 08:43
[AMGN]   Healthcare And Biotechnology Dashboard - Update  (Seeking Alpha)   14-Oct-19 11:00
[AMGN]   Amgen's Latest Data With KRAS G12C Inhibitor Drug Is Mixed, But Can Still Shine On Prior Evidence  (Seeking Alpha)   10-Oct-19 12:10
[AMGN]   The R.I.P. Portfolio's Q3 2019 Update  (Seeking Alpha)   8-Oct-19 12:30
[AMGN]   Amgen's AMG 510 Targeted Cancer Therapy  (Seeking Alpha)   4-Oct-19 14:55
[AMGN]   Provention Bio Is A Misunderstood Biotech With A Potential Quick Pathway To FDA Approval For Type 1 Diabetes Treatment  (Seeking Alpha)   3-Oct-19 10:59
[AMGN]   IPO Update: ADC Therapeutics Readies $200 Million IPO  (Seeking Alpha)   26-Sep-19 10:05
[AMGN]   Insulet: Low-Cost Pricing And Promising Pipeline To Drive Sales  (Seeking Alpha)   25-Sep-19 15:00
[AMGN]   IPO Update: Aprea Therapeutics Proposes IPO Terms  (Seeking Alpha)   24-Sep-19 12:14
[AMGN]   Replimune Group: Updates To Thesis, Data Approaching In Q4  (Seeking Alpha)   21-Sep-19 14:01
[AMGN]   Healthcare And Biotechnology Dashboard - Update  (Seeking Alpha)   18-Sep-19 02:10
[AMGN]   Lundbeck Makes A Large M&A Move, But The Target Will Be Somewhat Controversial  (Seeking Alpha)   17-Sep-19 08:15
[AMGN]   ADC Therapeutics Begins U.S. IPO Process  (Seeking Alpha)   16-Sep-19 12:48
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*